Pacific Biosciences of California

PACB · NASDAQ

$1.96+$0.12 (+6.52%)TodayMarket closed ·
Prev close $1.84

Latest news

  • Press releaseGlobe Newswire

    PacBio and Verily Health Announce Multi-Year Strategic Collaboration to Scale Long-Read Genomics for Biomedical AI

  • NewsAvi Kapoor

    Apogee Enterprises Posts Upbeat Q2 Earnings, Joins Constellation Energy, Freshworks And Other Big Stocks Moving Higher On Tuesday

  • Press releaseGlobe Newswire

    PacBio and TychoBio Collaborate to Train AI Models for Rare Disease RNA Therapeutics

  • NewsAvi Kapoor

    Progress Software, Nft And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session

  • Press releaseGlobe Newswire

    PacBio Announces Second Quarter 2026 Financial Results

  • NewsShivdeep Dhaliwal

    Cathie Wood Sells Robinhood Stock, Doubles Down On This George Soros-Backed AI Stock

  • Press releaseBusiness Wire

    Blank Bio Announces Seed Financing and Strategic Collaboration with PacBio to Advance RNA Foundation Models for Precision Oncology

  • Press releaseGlobe Newswire

    PacBio Announces First Quarter 2026 Financial Results

  • Press releaseGlobe Newswire

    PacBio and Lucid Genomics Announce Compatibility Collaboration to Advance Tertiary Analysis for Long-Read Sequencing

  • Press releaseGlobe Newswire

    PacBio and Covaris Announce Joint Workflow Enabling HiFi Long-Read Sequencing of FFPE Tumor Samples

  • Press releaseGlobe Newswire

    Basecamp Research Selects PacBio HiFi Sequencing to Power Trillion Gene Atlas Initiative

  • Press releaseGlobe Newswire

    PacBio Announces the Appointment of Chris Gibson to the Board of Directors

  • Press releaseGlobe Newswire

    PacBio and DNAstack Launch First Global Federated HiFi Whole Genome Dataset to Accelerate Rare Disease Research

  • News

    Insights into Pacific Biosciences Q4 Earnings

  • Press releaseGlobe Newswire

    PacBio Announces Fourth Quarter and Full Year 2025 Financial Results

  • Press releaseGlobe Newswire

    PacBio Joins iHope Initiative as First Long-Read Genomic Sequencing Partner

  • News

    Earnings Scheduled For February 12, 2026

  • News

    Uncovering Potential: Pacific Biosciences's Earnings Preview

  • News

    PacBio Plans Strategic Collaboration With n-Lorem Foundation And EspeRare To Advance Long-Read Whole-Genome Sequencing For Individualized ASO Therapies In Ultra-Rare Genetic Diseases

  • NewsErica Kollmann

    Cathie Wood's Biotech Trend: Twist, Beam, CRISPR Latest Stock Picks

  • News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Friday's Intraday Session

  • NewsAvi Kapoor

    Cloudflare Posts Upbeat Q3 Results, Joins Amazon, Roku, Coinbase, Atlassian And Other Big Stocks Moving Higher On Friday

  • NewsShivdeep Dhaliwal

    Cathie Wood Just Dumped $7.4 Million Worth Of Palantir And AMD Shares — Here's What Ark Is Buying Instead

  • NewsAvi Kapoor

    Applied Materials, GameStop And Other Big Stocks Moving Lower In Friday's Pre-Market Session

  • News

    The Analyst Verdict: Pacific Biosciences In The Eyes Of 4 Experts

  • Press releasePRNewswire

    Athena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene Sequencing

  • Press releaseBusiness Wire

    QIAGEN Expands NGS Portfolio with Launch of QIAseq xHYB Long Read Panels

  • News

    Beyond The Numbers: 4 Analysts Discuss Pacific Biosciences Stock

  • Press releasePRNewswire

    Target ALS Chooses PacBio HiFi Sequencing to Advance ALS Research with Largest Global Genomic Study to Date

  • News

    Where Pacific Biosciences Stands With Analysts

  • News

    Earnings Scheduled For May 8, 2025

  • Press releaseGlobe Newswire

    Davos Alzheimer's Collaborative Selects PacBio as Technology Partner for Global Project to Advance Alzheimer's Disease Research in North Africa

  • News

    Assessing Pacific Biosciences: Insights From 6 Financial Analysts

  • News

    Where Pacific Biosciences Stands With Analysts

  • News

    What Analysts Are Saying About Pacific Biosciences Stock

  • News

    10 Health Care Stocks Whale Activity In Today's Session

  • Press releasePRNewswire

    Volta Labs joins PacBio Compatible program to help PacBio customers scale sequencing through automated library prep

  • NewsAvi Kapoor

    Baidu, XPeng And Other Big Stocks Moving Lower In Monday's Pre-Market Session

  • NewsAvi Kapoor

    Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 47%; Here Are 20 Stocks Moving Premarket

  • NewsAvi Kapoor

    S&P 500 Moves Higher; BlackRock Reports Upbeat Results

  • NewsAvi Kapoor

    Gold Gains 1%; Wells Fargo Shares Gain After Q3 Earnings

  • NewsAvi Kapoor

    Fastenal Posts Upbeat Earnings, Joins Wells Fargo, JPMorgan And Other Big Stocks Moving Higher On Friday

  • Press releaseGlobe Newswire

    PacBio, A*STAR, and Macrogen Unveil State-of-the-Art Lab to Accelerate Genomics Innovation in Singapore

  • NewsAvi Kapoor

    Quanex Building Products Posts Better-Than-Expected Results, Joins Zumiez, Guidewire Software, Smartsheet And Other Big Stocks Moving Higher On Friday

  • News

    What 5 Analyst Ratings Have To Say About Pacific Biosciences

  • NewsAvi Kapoor

    Applied Materials, Amcor, RLX Technology And Other Big Stocks Moving Lower In Friday's Pre-Market Session

  • News

    Analyst Scoreboard: 5 Ratings For Pacific Biosciences

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.